Please login to the form below

Not currently logged in
Email:
Password:

Opioid

This page shows the latest Opioid news and features for those working in and with pharma, biotech and healthcare.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

The non-opioid painkiller was registered in Japan under the Tarlige brand name as a treatment for diabetic peripheral neuropathic pain (PNP) and postherpetic neuralgia (PHN) in January, and is a

Latest news

More from news
Approximately 15 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    About 2.5m people have been diagnosed with opioid dependence in the US, and almost one million are receiving treatment. ... New to the opioid dependence treatment market this year is CAM2038, marketed by Camurus, a company headquartered in Lund, Sweden.

  • Pharma deals continue to slide Pharma deals continue to slide

    These companies have been running out of cash and have had to do deals to stay alive.  Cerecor has sold its kappa opioid receptor antagonist in phase 2 to Janssen ... 74.5 (upfront 65). Cerecor (US). J&J/Janssen (US). Asset acquisition. CERC-501 phase

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    It has the potential to reduce pain without typical opioid therapy side effects and is in development for topical application in hypersensitivity disorders such as Bladder Pain Syndrome or Chronic Stump

  • How digital content helps HCPs curb opioid abuse through better prescribing decisions How digital content helps HCPs curb opioid abuse through better prescribing decisions

    In fact, a poll of physicians within our digital community found that 64% believe that doctors have a responsibility to help curb opioid abuse. ... And by delivering information concisely and in an engaging format, this approach is having a measurable

  • Deal Watch March 2016 Deal Watch March 2016

    $110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.

More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics